⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30206020 | 0.71 | KDM1A (0.31) | — | |
| SCHEMBL17028299 | 0.71 | KDM1A (0.31) | — | |
| SCHEMBL19946149 | 0.70 | NQO2 (0.35) | — | |
| SCHEMBL17433876 | 0.70 | APLNR (0.31) | — | |
| SCHEMBL2487490 | 0.68 | KDM1A (0.39) | — | |
| SCHEMBL1643790 | 0.67 | — | — | |
| SCHEMBL1339030 | 0.67 | MAPT (0.30) | — | |
| SCHEMBL17434001 | 0.65 | SLC6A4 (0.36) | — | |
| SCHEMBL31039433 | 0.65 | CES2 (0.32) | — | |
| SCHEMBL500769 | 0.65 | CES2 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680612-A1 | CHEMICAL COMPOUNDS | AN2 Therapeutics, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024192309-A1 | CHEMICAL COMPOUNDS | REACTIVE BIOSCIENCES, INC. (US) | 2024-09-19 | — | — | WO | disclosed |